The Thyroid Conversion Problem — T4, T3, Reverse T3, and Why the Standard Test Misses It

Thyroid Hormone Synthesis — Building T4 in the Follicle

Thyroid hormone synthesis begins in the thyroid follicular cells with three raw materials: iodine, the amino acid tyrosine, and oxygen. Iodide is actively transported from the bloodstream into follicular cells by the sodium-iodide symporter (NIS) — a process driven by the sodium gradient maintained by Na/K-ATPase. Inside the cell, iodide is oxidised to iodine by thyroid peroxidase (TPO), a haem-containing enzyme that requires hydrogen peroxide as an oxidant. This oxidation step is the one targeted by TPO antibodies in Hashimoto's thyroiditis — the autoimmune attack disrupts the very enzyme that produces thyroid hormone.

Iodine is then incorporated into tyrosine residues on thyroglobulin — a large glycoprotein stored in the follicular lumen. Single iodination of tyrosine produces monoiodotyrosine (MIT). Double iodination produces diiodotyrosine (DIT). TPO then couples these iodinated tyrosines: one MIT + one DIT produces T3 (triiodothyronine, three iodine atoms). Two DIT molecules coupled produce T4 (thyroxine, four iodine atoms). The thyroid gland produces predominantly T4 — approximately 80–90% of thyroid secretion — with only 20% direct T3 output.

Transport in Circulation — Bound and Free Fractions

T4 secreted from the thyroid gland enters the bloodstream, where it is almost entirely bound to transport proteins: thyroxine-binding globulin (TBG, binding approximately 70% of T4), transthyretin (binding 10–15%), and albumin (binding 15–20%). Only the tiny unbound fraction — Free T4, approximately 0.03% of total T4 — is available for cellular uptake and conversion to T3. This is why Free T4 is the clinically meaningful measurement rather than total T4.

TBG levels are regulated by several hormones. Oestrogen increases TBG production — pregnancy, oral contraceptives, and oestrogen therapy all raise TBG, lowering the Free T4 fraction even when total T4 appears normal. This is one mechanism through which oestrogen dominance can produce functional hypothyroid symptoms with apparently normal thyroid function tests. Androgens and glucocorticoids have the opposite effect — reducing TBG and increasing Free T4 availability. This is another reason why interpreting thyroid markers without hormonal context is insufficient.

The Deiodinase Enzymes — Where T4 Becomes T3

T4 is a prohormone. It has minimal intrinsic biological activity. Its function is to serve as a circulating reservoir for T3 — the active form that binds to thyroid hormone receptors in the cell nucleus and drives gene expression. The conversion from T4 to T3 is performed by a family of selenoprotein enzymes called deiodinases — so named because they remove specific iodine atoms from the T4 molecule.

Type 1 deiodinase (D1) is expressed primarily in the liver, kidney, and thyroid. It performs outer-ring deiodination — removing the iodine from the outer ring of T4 to produce T3. D1 is the primary source of circulating T3, accounting for approximately 80% of systemic T3 production. D1 activity is reduced by selenium deficiency, hypothyroidism itself (a self-limiting cycle), propylthiouracil (the antithyroid drug), and by elevated reverse T3 competing for the enzyme.

Type 2 deiodinase (D2) is expressed in the brain, pituitary, skeletal muscle, heart, and brown adipose tissue. It also performs outer-ring deiodination, producing T3 locally within these tissues from local T4 uptake. D2 is the primary source of T3 for the central nervous system and is the enzyme responsible for the pituitary's local T3 production — the T3 that feeds back to suppress TSH. This creates a critical clinical blind spot: the pituitary has its own local T4→T3 conversion via D2, so TSH reflects pituitary T3 availability, not peripheral tissue T3 availability.

Type 3 deiodinase (D3) performs inner-ring deiodination — removing the iodine from the inner ring of T4. This produces reverse T3 (rT3), an inactive isomer that cannot activate thyroid hormone receptors. D3 is expressed in placenta, brain, skin, and various other tissues. It is the primary enzyme responsible for thyroid hormone inactivation — a physiological mechanism for reducing thyroid hormone effect at the tissue level during foetal development, illness, caloric restriction, and chronic stress.

Reverse T3 — The Inactive Competitor

Reverse T3 is structurally identical to T3 except for the position of one iodine atom. T3 has iodine on the 3 and 5 positions of the inner ring and the 3' position of the outer ring. Reverse T3 has iodine on the 3 and 5 positions of the outer ring and the 3' position of the inner ring. This single positional difference means rT3 cannot activate the thyroid hormone receptor despite binding to it — it occupies the receptor without producing the conformational change required for receptor activation. rT3 is therefore a competitive antagonist to T3 at the receptor level.

In healthy physiology, rT3 is a short-lived circulating metabolite that is rapidly cleared. In states of physiological stress, significant illness, caloric restriction, or chronic cortisol elevation, D3 activity is upregulated relative to D1/D2. More T4 is shunted toward rT3 rather than T3. rT3 clearance can also be impaired (rT3 is normally further deiodinated to T2 by D1 — reduced D1 activity means rT3 accumulates). The result is elevated circulating rT3 that competes with the already-reduced T3 at receptor sites.

This is the mechanism of functional hypothyroidism in chronic stress, burnout, significant illness, and aggressive caloric restriction. The thyroid gland is producing T4 normally. TSH is normal — the pituitary is making its own T3 locally via D2 and sees no problem. But peripheral tissues are receiving inadequate T3 because D1 conversion is reduced and rT3 competition at receptors is elevated. Every tissue-level hypothyroid symptom — fatigue, brain fog, cold intolerance, weight gain, poor recovery, constipation, hair thinning — can be present with a completely normal TSH and Free T4.

Why TSH Alone Fails — The Pituitary Is Not a Window Into Peripheral Tissue

The TSH test measures the pituitary's output of thyroid stimulating hormone — which reflects the pituitary's own assessment of its T3 supply. The pituitary is unusual among body tissues in having very high D2 activity and therefore converting a large proportion of its local T4 to T3 intracellularly. This local T3 drives TSH suppression through the nuclear thyroid receptor in pituitary thyrotroph cells.

When D1 activity is reduced (selenium deficiency, cortisol elevation, inflammation), peripheral tissue T3 falls. But the pituitary's D2 pathway is less affected — the pituitary continues converting adequate T4 to T3 locally, suppressing TSH normally. TSH appears normal. The peripheral deficit is invisible to the standard test.

Additionally, the TSH reference range was established from population data that included people with subclinical thyroid disease. The upper limit of 4.5 mIU/L used by most laboratories is a statistical boundary, not a health boundary. Multiple studies have shown that TSH values above 2.0 mIU/L in the presence of symptoms are associated with reduced Free T3, elevated TPO antibody risk, and reduced quality of life outcomes. The functional optimal range of 0.5–2.0 mIU/L is not an arbitrary narrowing — it reflects the TSH range associated with optimal peripheral thyroid hormone effect.

What Disrupts Conversion — The Upstream Drivers

Impaired T4→T3 conversion and elevated rT3 production are not primary thyroid problems. They are secondary responses to upstream physiological conditions. Identifying and addressing the upstream driver is the clinical priority — treating the conversion problem without identifying its cause produces temporary improvement at best.

Cortisol — the most common upstream driver

Cortisol at chronically elevated levels has three distinct anti-thyroid effects. First, it upregulates D3 (inner-ring deiodination), shunting more T4 toward rT3. Second, it downregulates D1 and D2 (outer-ring deiodination), reducing T4→T3 conversion. Third, it reduces the sensitivity of peripheral thyroid hormone receptors through glucocorticoid-receptor-mediated epigenetic changes. The net effect is that a person with chronically elevated cortisol — identifiable on the DUTCH Plus CAR pattern — is simultaneously producing less T3 from T4, producing more rT3 from T4, and responding less well to whatever T3 is available. This is the mechanism behind the frequently observed clinical pattern of HPA axis dysregulation presenting with hypothyroid symptoms despite normal TSH.

Caloric restriction

Energy restriction is one of the most potent stimuli for rT3 elevation. The body interprets sustained caloric deficit as a survival threat and responds by down-regulating metabolic rate — partly through reducing T3 availability at the peripheral tissue level. D3 is upregulated, D1 is downregulated, and rT3 accumulates. This is the metabolic adaptation that makes prolonged aggressive caloric restriction counterproductive — the very restriction intended to drive weight loss reduces metabolic rate through reduced T3 action, making subsequent fat loss progressively harder. It is also why TSH remains normal during caloric restriction — the mechanism is at the conversion level, not the pituitary level.

Systemic inflammation

Pro-inflammatory cytokines — particularly IL-6, IL-1β, and TNF-α — independently suppress D1 activity and upregulate D3. Any source of chronic systemic inflammation produces the same conversion impairment as cortisol. This is the mechanism of “sick euthyroid syndrome” — observed in acute illness where T3 falls and rT3 rises despite normal TSH, as an adaptive metabolic brake. In chronic low-grade inflammation from gut dysbiosis, metabolic syndrome, or environmental toxin burden, the same mechanism operates continuously at lower amplitude.

Iron deficiency

Iron is required for the haem group in thyroid peroxidase (TPO) — the enzyme that iodidates thyroglobulin during synthesis. Iron deficiency impairs TPO function, reducing thyroid hormone synthesis. But iron also affects peripheral conversion: ferritin below 70 µg/L is consistently associated with elevated TPO antibodies in clinical practice — low ferritin appears to increase autoimmune thyroid susceptibility. The mechanism likely involves impaired mitochondrial electron transport (iron-dependent) reducing the energy available for the T4→T3 conversion reaction.

Gut dysbiosis

Approximately 20% of T4→T3 conversion occurs in the gut — performed by intestinal deiodinase enzymes expressed by gut epithelial cells, and by sulphatase enzymes produced by commensal bacteria that deconjugate inactive thyroid hormone sulphate back to active T3. Significant gut dysbiosis — reduced bacterial diversity, depleted commensals — reduces this gut-derived T3 contribution. Additionally, gut-derived LPS activates systemic inflammation, which then suppresses hepatic D1 through the cytokine pathway described above. The gut-thyroid axis operates through two concurrent mechanisms.

The Gut-Thyroid Axis — Molecular Mimicry and Microbiome Conversion

The connection between gut health and thyroid function is more direct than the systemic inflammation route alone. Hashimoto's thyroiditis — the most common autoimmune thyroid condition — has a specific gut connection through molecular mimicry. Gliadin, the protein component of gluten, shares amino acid sequence homology with thyroid peroxidase. In a person with compromised gut barrier integrity (elevated zonulin), incompletely digested gliadin fragments cross into the subepithelial space, are presented to the immune system, and the resulting anti-gliadin antibodies can cross-react with TPO — contributing to the autoimmune attack on the thyroid. This is the molecular basis for the observation that strict gluten elimination consistently reduces TPO antibody titres in susceptible individuals.

The GI-MAP provides three markers directly relevant to thyroid function: anti-gliadin secretory IgA (confirming active mucosal immune reactivity to gliadin), zonulin (confirming the gut barrier compromise that allows gliadin fragments to reach the systemic immune system), and the overall commensal ecology profile that determines both gut-derived T3 conversion contribution and systemic inflammatory load.

Restoring Conversion — What Works and Why

What to Test — The Complete Thyroid Assessment